Year: 2023

LAS VEGAS, Dec. 28, 2023 (GLOBE NEWSWIRE) — Healthy Extracts Inc. (OTCQB: HYEX, HYEXD), a platform for acquiring, developing, patenting, marketing, and distributing plant-based nutraceuticals that target select high-growth categories within the multibillion-dollar nutraceuticals market, will effect a 1-for-120 reverse split of its common stock, effective at the opening of the market tomorrow, Friday, December 29, 2023.    The reverse stock split will be implemented in connection with the company’s intention to uplist the company’s common stock to the NYSE American. The reverse split is intended to fulfill the stock price requirements for a listing on the NYSE American stock exchange, which requires that the company’s common stock be priced at $3.00 or higher at the time of listing. The company is taking steps to satisfy...

MONTREAL, Dec. 28, 2023 (GLOBE NEWSWIRE) — HPQ Silicon Inc. (“HPQ” or the “Company”) (TSX-V: HPQ) (OTCQB: HPQFF) (FRA: O08), a technology company specializing in green engineering processes for silica and silicon material manufacturing announces that on December 28, 2023, HPQ Board of Directors has granted the following incentive stock options under the company’s 2021 Stock Option Plan to directors, officers, employees, and consultants of the company entitling the option holders to acquire an aggregate of 9,800,000 common shares of the company. These options are exercisable at a price of $0.215 per share and will expire on December 28th, 2028. Each share issued pursuant to those grants will have a mandatory four (4) months and one (1) day holding period from the date of the grant of the options. About HPQ Silicon HPQ Silicon...

TORONTO, Dec. 28, 2023 (GLOBE NEWSWIRE) — Dundee Corporation (TSX: DC.A, DC.PR.B and DC.PR.D) (“Dundee” or the “Corporation”) announced today the results of its substantial issuer bid (the “Offer”) to purchase for cancellation from the holders thereof who chose to participate up to 975,610 of its issued and outstanding Cumulative Floating Rate First Preference Shares, Series 3 in the capital of the Corporation (the “Series 3 Shares”) at a purchase price of C$20.50 per Series 3 Share, for a maximum aggregate purchase price of C$20,000,005. The Offer expired at 11:59 p.m. (Toronto time) on December 27, 2023. Based on the report of Computershare Investor Services Inc., as depositary for the Offer (the “Depositary”), 914,040 Series 3 Shares were tendered to the Offer. In accordance with the terms and conditions of the Offer and based...

  Regulated information – Inside informationNo bankruptcy filing Significant reduction in Working Capital costs Atlas commits to fund Oxurion’s Working Capital costs (including the Preclinical GA Program) through 2024 using the existing Atlas Funding Program, under the conditions as set out below Intent to put in place Debt Restructuring plan Two new independent directors have been co-opted to the Board, and a new CEO/CFO, who will also act as an executive board member, have been appointed upon proposal of AtlasLeuven, BELGIUM – December 28, 2023 – 9:00 PM CET – Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, announced today it has avoided bankruptcy by entering into a binding letter of intent (LOI) with Atlas Special Opportunities LLC (Atlas) and an addendum to the existing subscription...

CHESTERBROOK, Pa., Dec. 28, 2023 (GLOBE NEWSWIRE) — Trevena, Inc. (“Trevena” or the “Company”) (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced that it has closed its previously announced offering for the issuance and sale of 2,779,906 shares of common stock (or pre-funded warrants in lieu thereof) of Trevena and warrants to purchase up to an aggregate of 2,779,906 shares of common stock of Trevena, at a purchase price of $0.70 per share (or pre-funded warrant in lieu thereof) and associated warrant in a private placement, for gross proceeds to the Company of approximately $1.946 million (the “private placement”). Pursuant to a previously announced definitive agreement with respect to the immediate...

Board member Ronica Wang has decided to step down from the Board of Directors of GN Store Nord A/S. Consequently, GN’s Board of Directors as of today consists of Jukka Pekka Pertola (Chair), Klaus Holse (Deputy chair), Anette Weber, Hélène Barnekow, and members elected by the employees: Leo Larsen, Cathrin Inge Hansen, and Claus Holmbeck-Madsen. For further information, please contact: Investor RelationsAnne Sofie Staunsbæk Veyhe +45 45 75 85 06Rune Sandager +45 45 75 92 57 Media Relations Steen Frentz Laursen +45 20 65 34 20 About GN GN facilitates communication between people through intelligent hearing, audio, video, and gaming technology. Inspired by people and driven by our passion for innovation, we leverage technologies to deliver unique user experiences that bring people closer through the power of sound and vision. GN was founded...

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. VANCOUVER, British Columbia, Dec. 28, 2023 (GLOBE NEWSWIRE) — ATHA Energy Corp. (CSE: SASK) (FRA: X5U) (OTCQB: SASKF) (“ATHA” or the “Company”) is pleased to announce that, further to its press releases dated December 7, 2023, ATHA has completed a private placement offering of: (i) 8,363,710 charitable federal flow-through common shares of ATHA (the “Federal CFT Shares”) at an issue price per Federal CFT Share of $1.57 and 3,636,290 charitable Saskatchewan flow-through common shares of ATHA (the “Saskatchewan CFT Shares” and, together with the Federal CFT Shares, the “Offered Shares”) at an issue price per Saskatchewan CFT Share of $1.75 (the “CFT Offering”); and (ii) 4,000,000 subscription receipts of ATHA (the “Subscription Receipts”)...